Ordás I - Search Results

1

Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity.

Rimola J, Ordás I, Rodriguez S, García-Bosch O, Aceituno M, Llach J, Ayuso C, Ricart E, Panés J. Rimola J, et al. Among authors: ordas i. Inflamm Bowel Dis. 2011 Aug;17(8):1759-68. doi: 10.1002/ibd.21551. Epub 2010 Nov 8. Inflamm Bowel Dis. 2011. PMID: 21744431 Clinical Trial.

2

Are we giving biologics too late? The case for early versus late use.

Ricart E, García-Bosch O, Ordás I, Panés J. Ricart E, et al. Among authors: ordas i. World J Gastroenterol. 2008 Sep 28;14(36):5523-7. doi: 10.3748/wjg.14.5523. World J Gastroenterol. 2008. PMID: 18810770 Free PMC article. Review.

3

Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease.

Rimola J, Rodriguez S, García-Bosch O, Ordás I, Ayala E, Aceituno M, Pellisé M, Ayuso C, Ricart E, Donoso L, Panés J. Rimola J, et al. Among authors: ordas i. Gut. 2009 Aug;58(8):1113-20. doi: 10.1136/gut.2008.167957. Epub 2009 Jan 9. Gut. 2009. PMID: 19136510 Free article.

4

Risk factors and characteristics of extent progression in ulcerative colitis.

Etchevers MJ, Aceituno M, García-Bosch O, Ordás I, Sans M, Ricart E, Panés J. Etchevers MJ, et al. Among authors: ordas i. Inflamm Bowel Dis. 2009 Sep;15(9):1320-5. doi: 10.1002/ibd.20897. Inflamm Bowel Dis. 2009. PMID: 19235909

5

Colonic Crohn's disease: value of magnetic resonance colonography for detection and quantification of disease activity.

Rimola J, Ordás I, Rodríguez S, Panés J. Rimola J, et al. Among authors: ordas i. Abdom Imaging. 2010 Aug;35(4):422-7. doi: 10.1007/s00261-009-9545-4. Epub 2009 Jun 18. Abdom Imaging. 2010. PMID: 19536590

6

Optimizing the use of tumour necrosis factor inhibitors in Crohn's disease: a practical approach.

Etchevers MJ, Ordás I, Ricart E. Etchevers MJ, et al. Among authors: ordas i. Drugs. 2010;70(2):109-20. doi: 10.2165/11533700-000000000-00000. Drugs. 2010. PMID: 20108987 Review.

7

[Rationale for cell therapy in the treatment of inflammatory bowel disease].

Ordás I, Salas A, Benítez D, Ricart E, Panés J. Ordás I, et al. Gastroenterol Hepatol. 2010 Dec;33(10):716-20. doi: 10.1016/j.gastrohep.2010.01.003. Epub 2010 Apr 8. Gastroenterol Hepatol. 2010. PMID: 20381204 Review. Spanish.

8

Stem cell treatment for Crohn's disease.

Panés J, Ordás I, Ricart E. Panés J, et al. Among authors: ordas i. Expert Rev Clin Immunol. 2010 Jul;6(4):597-605. doi: 10.1586/eci.10.27. Expert Rev Clin Immunol. 2010. PMID: 20594133

9

Anti-TNF antibody therapy in Crohn's disease: the risk of a switch.

Ricart E, Ordás I, Panés J. Ricart E, et al. Among authors: ordas i. Gut. 2012 Feb;61(2):169-70. doi: 10.1136/gutjnl-2011-301478. Epub 2011 Nov 7. Gut. 2012. PMID: 22068167 No abstract available.

10

Imaging indexes of activity and severity for Crohn's disease: current status and future trends.

Rimola J, Ordás I, Rodríguez S, Ricart E, Panés J. Rimola J, et al. Among authors: ordas i. Abdom Imaging. 2012 Dec;37(6):958-66. doi: 10.1007/s00261-011-9820-z. Abdom Imaging. 2012. PMID: 22072290 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters